immune system
N |
• despite displaying granulocytosis, mice exhibit normal numbers of common myeloid precursors, granulocytic and monocytic precursors, and megakaryocytic and erythroid precursors
|
• following treatment with DSS, mice exhibit more severe damage and inflammatory infiltration of the mucosa of the colon, increased weight loss and higher fecal scores compared to similarly treated wild-type mice
|
• at 9 months
|
• B cell production is hampered in the bone marrow and spleen
|
• mice exhibit granulocytes with enlarged cellular and nuclear sizes unlike in wild-type mice
|
• beginning 6 weeks after birth and progressing with age
|
• mice exhibit an increase in the percentages of CD44highCD62Lhigh memory T cells in the CD4+ splenic compartments compared to in wild-type mice
|
• mice exhibit a decreased in the number of CD44lowCD62Lhigh naive T cells in the CD4+ and CD8+ compartments of the spleen compared to in wild-type mice
|
• mice exhibit an increase in the percentages of CD44highCD62Llow effector T cells in the CD4+ and CD8+ splenic compartments compared to in wild-type mice
|
• cell autonomous granulocyte proliferation and survivability is increased leading to the development of chronic myelocytic leukemia
|
• mice exhibit reduced Peyer's patch numbers associated with increased apoptosis in the Peyer's patches compared to wild-type mice
|
• mice exhibit reduced Peyer's patch size associated with increased apoptosis in the Peyer's patches compared to wild-type mice
|
neoplasm
• chronic myelocytic leukemia develops at 9 months with enlarged spleens infiltrated with granulocytes
• by 16 months, 90% of mice exhibit chronic myelocytic leukemia
• granulocyte proliferation and survivability is increased leading to the development of chronic myelocytic leukemia
|
growth/size/body
weight loss
(
J:139868
)
• from 3 months of age
|
• at 9 months
|
digestive/alimentary system
• following treatment with DSS, mice exhibit more severe damage and inflammatory infiltration of the mucosa of the colon, increased weight loss and higher fecal scores compared to similarly treated wild-type mice
|
hematopoietic system
• at 9 months
|
• B cell production is hampered in the bone marrow and spleen
|
• decreased erythroid production in the bone marrow is compensated for by increased erythropoiesis in the spleen
|
• mice exhibit granulocytes with enlarged cellular and nuclear sizes unlike in wild-type mice
|
• beginning 6 weeks after birth and progressing with age
|
• mice exhibit an increase in the percentages of CD44highCD62Lhigh memory T cells in the CD4+ splenic compartments compared to in wild-type mice
|
• mice exhibit a decreased in the number of CD44lowCD62Lhigh naive T cells in the CD4+ and CD8+ compartments of the spleen compared to in wild-type mice
|
• mice exhibit an increase in the percentages of CD44highCD62Llow effector T cells in the CD4+ and CD8+ splenic compartments compared to in wild-type mice
|
• cell autonomous granulocyte proliferation and survivability is increased leading to the development of chronic myelocytic leukemia
|